Amaia Arruabarrena-Aristorena
6PUBLICATIONS
55CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 11, 2025
The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer.Srushti Kittane, Erik Ladewig, Taibo Li
|Apr 20, 2022
The Oncogenic PI3K-Induced Transcriptomic Landscape Reveals Key Functions in Splicing and Gene Expression Regulation.Erik Ladewig, Flavia Michelini, Komal Jhaveri
|Feb 24, 2022
PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer.Amaia Zabala-Letona, Amaia Arruabarrena-Aristorena, Sonia Fernandez-Ruiz
|Oct 02, 2020
TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors.Emiliano Cocco, Ji Eun Lee, Srinivasaraghavan Kannan
|Oct 02, 2019
Targeting PML in triple negative breast cancer elicits growth suppression and senescence.Leire Arreal, Marco Piva, Sonia Fernández
|Jan 30, 2018
Oil for the cancer engine: The cross-talk between oncogenic signaling and polyamine metabolism.Amaia Arruabarrena-Aristorena, Amaia Zabala-Letona, Arkaitz Carracedo
Pageof 1
Frequent Collaborators
3 joint publications
Arkaitz Carracedo
3 joint publications
Maurizio Scaltriti
2 joint publications
Emiliano Cocco
2 joint publications
Srinivasaraghavan Kannan
2 joint publications
Pau Castel
2 joint publications
Eneda Toska
2 joint publications
Christina S Leslie
2 joint publications
Erik Ladewig
1 joint publications
Rosa Barrio
1 joint publications
Ji Eun Lee
